Insulet

YTD

ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals.

CEO

Ashley A. McEvoy

CEOAshley A. McEvoy

Employees

5,400

Employees5,400

Headquarters

Acton, Massachusetts

HeadquartersActon, Massachusetts

Founded

2000

Founded2000

Employees

5,400

Employees5,400

PODD Key Statistics

Market cap

17.36B

Market cap17.36B

Price-Earnings ratio

70.88

Price-Earnings ratio70.88

Dividend yield

—

Dividend yield—

Average volume

1.27M

Average volume1.27M

High today

$252.63

High today$252.63

Low today

$245.66

Low today$245.66

Open price

$248.74

Open price$248.74

Volume

974.59K

Volume974.59K

52 Week high

$354.88

52 Week high$354.88

52 Week low

$230.05

52 Week low$230.05

Stock Snapshot

Insulet(PODD) stock is priced at $246.61, giving the company a market capitalization of 17.36B. It carries a P/E multiple of 70.88.

As of 2026-03-01, Insulet(PODD) stock has fluctuated between $245.66 and $252.63. The current price stands at $246.61, placing the stock +0.4% above today's low and -2.4% off the high.

Insulet(PODD) shares are trading with a volume of 974.59K, against a daily average of 1.27M.

In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $230.05.

PODD News

Simply Wall St 8h

Strong Revenue Growth And Upbeat 2026 Outlook Might Change The Case For Investing In Insulet

In February 2026, Insulet Corporation reported fourth-quarter 2025 sales of US$783.8 million and full-year revenue of US$2.71 billion, with annual net income of...

TipRanks 2d

Insider Move: Major Director Buy Signals Fresh Confidence in Insulet

New insider activity at Insulet ( (PODD) ) has taken place on February 26, 2026. Insulet director Michael Minogue has signaled confidence in the company by pur...

Simply Wall St 5d

Insulet Expands Buyback As Shares Trade Below Analyst And Fair Value Estimates

Insulet, NasdaqGS:PODD, has approved a significant increase in its share buyback authorization. The company also extended the duration of its equity repurchase...

Analyst ratings

93%

of 29 ratings

Buy

93.1%

Hold

3.4%

Sell

3.4%

More PODD News

Nasdaq 6d

Monday 2/23 Insider Buying Report: PODD, ARW

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably...

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.